|
⚲
|
| Keyboard |
| Green Nicholas Stewart
✚
|
|
|---|---|
| CIK # | 0001817685 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001817685] | |
| 4 | [0001817685] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| Green Nicholas Stewart |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 455,512 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-02-05 | Disposed to issuer | 159,375 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 308,486 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 11,755 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 75,000 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 54,455 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-31 | Other | 1,755 | $6.05 | 10,618 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-26 | Sell | 57,675 | $12.22 | 704,788 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-26 | Sell | 88,236 | $12.22 | 1,078,244 |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 51,339 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2023 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 47,073 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-25 | Option exercise | 119,973 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-25 | Option exercise | 183,558 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2024 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 45,215 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2023 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 47,073 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2024 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 45,215 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2025 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 91,270 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2025 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 91,270 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 16,721 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 26,479 | $0.00 | |
| showing 20 of 120 most recent transactions | |||||